切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2022, Vol. 16 ›› Issue (02) : 222 -225. doi: 10.3877/cma.j.issn.1674-3946.2022.02.028

论著

ESD治疗十二指肠非壶腹部侧向发育型肿瘤的安全性和有效性研究
陈波1,(), 彭超1, 谭小辉1, 王国仲1, 涂元茂1   
  1. 1. 641000 四川内江,内江市第二人民医院普外科
  • 收稿日期:2021-03-18 出版日期:2022-04-26
  • 通信作者: 陈波

The safety and efficacy of ESD in the treatment of non-ampullary duodenal laterally spreading tumors

Bo Chen1,(), Chao Peng1, Xiaohui Tan1, Guozhong Wang1, Yuanmao Tu1   

  1. 1. General surgery Department, Neijiang Second People’s Hospital, Neijiang Sichuan Province 641000, China
  • Received:2021-03-18 Published:2022-04-26
  • Corresponding author: Bo Chen
  • Supported by:
    Project of Sichuan Medical Research Project(S18082); Technical Extension Project for Health Matters in Sichuan Province(19SYJS11)
引用本文:

陈波, 彭超, 谭小辉, 王国仲, 涂元茂. ESD治疗十二指肠非壶腹部侧向发育型肿瘤的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2022, 16(02): 222-225.

Bo Chen, Chao Peng, Xiaohui Tan, Guozhong Wang, Yuanmao Tu. The safety and efficacy of ESD in the treatment of non-ampullary duodenal laterally spreading tumors[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2022, 16(02): 222-225.

目的

观察内镜粘膜剥离术(ESD)治疗十二指肠非壶腹部侧向发育型肿瘤(LSTs)的安全性和有效性。

方法

前瞻性研究2017年1月至2020年6月62例十二指肠非壶腹部LSTs的临床资料,采用随机数字表法将患者分为两组:内镜黏膜切除术(EMR)组行内镜黏膜切除术,ESD组行内镜黏膜剥离术,每组各31例。数据应用软件SPSS 22.0处理。围术期相关指标、炎性指标等计量资料采用(

xˉ
±s)表示,行独立样本t检验;术后并发症等计数资料行χ2检验;生存分析采用Kaplan-Meier法并行Log-rank检验。P<0.05差异有统计学意义。

结果

ESD组手术时间较EMR组显著增加,而ESD组术中出血量、整块切除率、R0切除率、术后住院时间显著优于EMR组(P<0.05),两组术后并发症情况比较差异无统计学意义(P>0.05);两组患者术后24 h C反映蛋白(CRP)、白细胞介素6(IL-6)、肿瘤坏死因子α(TNF-α)水平较术前均显著增高,且ESD组三项水平均显著低于EMR组,差异均有统计学意义(P<0.05);中位随访23个月,累积无病生存率:EMR组患者为80.6%,ESD组患者为100%,两组差异有统计学意义(P<0.05)。

结论

ESD治疗十二指肠非壶腹部LSTs是安全有效的,不仅能够有效的控制手术风险,而且具有更好的切除效果,并提高了患者的预后。

Objective

To observe the safety and efficacy of endoscopic submucosal dissection(ESD)in the treatment of non-ampullary duodenal laterally spreading tumors(LSTs).

Methods

The clinical data of 62 cases of non-ampullary duodenal LSTs from January 2017 to June 2020 were selected,and the patients were randomly divided into two groups:the ESD group and EMR group,with 31 cases in each group. The EMR group underwent endoscopic mucosal resection,and the ESD group underwent endoscopic submucosal dissection. Data processing software SPSS 22.0. Perioperative relevant indexes,inflammatory indexes and other measurement data were expressed by(

xˉ
±s),and independent t test was performed. Postoperative complications were counted by χ2 test. Kaplan-Meier parallel log-rank test was used for survival analysis(P<0.05)was statistically significant.

Results

The operation time of ESD group was significantly longer than that of EMR group,while the intraoperative blood loss,total resection rate,R0 resection rate and postoperative hospital stay of ESD group were significantly better than those of EMR group(P<0.05),and there was no significant difference in postoperative complications between the two groups(P>0.05). The levels of CRP,IL-6 and TNF-α in both groups were significantly increased 24 h after surgery,and the three levels in ESD group were significantly lower than those in EMR group,the differences were statistically significant(P<0.05).The median follow-up period was 23 months,the cumulative disease-free survival rate was 80.6% in the EMR group and 100% in the ESD group,he difference between the two groups was statistically significant(P<0.05).

Conclusion

ESD treatment of non-ampullary duodenal LSTs is safe and effective,Which can not only effectively control the risk of surgery,but also has better effect of resection,and improve the prognosis of patients.

表1 62例十二指肠非壶腹部LSTs不同术式两组患者一般资料[(
xˉ
±s),例]
表2 62例十二指肠非壶腹部LSTs不同术式两组患者围手术期相关指标[(
xˉ
±s),例]
表3 62例十二指肠非壶腹部LSTs不同术式两组患者术前、术后24 h炎性指标水平(
xˉ
±s
图1 62例十二指肠非壶腹部LSTs不同术式两组患者累积无病生存曲线
[1]
Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer[J]. Endoscopy199325(7):455-461.
[2]
冯轶,牛应林,李鹏,等. 结直肠侧向发育型肿瘤的内镜表现及病理特点研究[J]. 中国内镜杂志201925(1):79-84.
[3]
谢静,王东,李兆申. ESD和隧道技术经口内镜下肌切开术(POEM)[J/CD]. 中华普外科手术学杂志(电子版)201711(2):174-176.
[4]
张艳飞. 大肠侧向发育型肿瘤的诊断及内镜治疗进展[J]. 中国微创外科杂志201717(12):1117-1120,1125.
[5]
Zou J,,Chai N,,Linghu E,et al. Clinical outcomes of endoscopic resection for non-ampullary duodenal laterally spreading tumors[J]. Surg Endosc201933(12):4048-4056.
[6]
鲁斌,于红刚. 内镜下不同治疗方法对大肠侧向发育型肿瘤的治疗价值的探讨[J]. 临床消化病杂志201830(6):32-36.
[7]
曾德辉,汪福群,王胜炳. 内镜黏膜下剥离术治疗大肠侧向发育型肿瘤的临床效果[J]. 中国当代医药202027(5):111-113.
[8]
金燕,姚礼庆,龚镭,等. 内镜治疗十二指肠非壶腹性黏膜病变的回顾性分析[J]. 中华消化内镜杂志202138(1):62-65.
[9]
Esaki M,,Suzuki S,,Ikehara H,et al. Endoscopic diagnosis and treatment of superficial non-ampullary duodenal tumors[J]. World J Gastrointest Endosc201810(9):156-164.
[10]
Valerii G,,Tringali A,,Landi R,et al. Endoscopic mucosal resection of non-ampullary sporadic duodenal adenomas:a retrospective analysis with long-term follow-up[J]. Scand J Gastroenterol201853(4):490-494.
[11]
隗永秋,周巧直,李鹏,等. 内镜分片黏膜切除术及黏膜下剥离术治疗十二指肠非壶腹部较大占位的临床观察[J]. 中华消化内镜杂志201936(12):901-905.
[12]
梁丽,于妍斐,张继新,等. 113例早期结直肠癌及癌前病变内镜黏膜下剥离术标本处理及病理学评估[J]. 中华消化内镜杂志201835(7):470-476.
[13]
Guo HM,,Ling TS,,Wang L,et al. Clinical outcomes of endoscopic submucosal dissection for laterally spreading tumors involving the dentate line[J]. J Dig Dis201920(2):83-88.
[14]
Bogie RMM,,Veldman MHJ,,Snijders LARS,et al. Endoscopic subtypes of colorectal laterally spreading tumors(LSTs)and the risk of submucosal invasion:a meta-analysis[J]. Endoscopy201850(3):263-282.
[15]
汤勇,卢洪,黄志勇. ESD治疗早期结直肠癌及癌前病变疗效观察[J]. 中国现代普通外科进展202023(7):557-559.
[16]
Nishizawa T,,Yahagi N. Endoscopic mucosal resection and endoscopic submucosal dissection:technique and new directions[J]. Curr Opin Gastroenterol201733(5):315-319.
[17]
高千惠,孙明军. 403例大肠侧向发育型肿瘤内镜下诊治分析[J]. 中华消化内镜杂志201835(9):625-629.
[18]
Tanaka S,,Kashida H,,Saito Y,et al. Japan Gastroenterological Endoscopy Society guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection[J]. Dig Endosc202032(2):219-239.
[19]
王征球,龚建涛,杨晓军,等. 经内镜逆行胰胆管造影术治疗高龄胆总管结石患者的疗效、安全性及对炎症反应的影响分析[J]. 中国中西医结合消化杂志201927(2):19-22.
[1] 贺敬龙, 尚宏喜, 郝敏, 谢伟, 高明宏, 孙炜, 刘安庆. 重度类风湿关节炎患者行多关节置换术的临床手术疗效[J]. 中华关节外科杂志(电子版), 2023, 17(06): 860-864.
[2] 杜滨和, 徐楠, 杨云川, 崔培元. 5项改良衰弱指数预测胰十二指肠切除术近期预后的价值探讨[J]. 中华普通外科学文献(电子版), 2023, 17(06): 444-448.
[3] 袁成雪, 张宗霞, 许婷, 斯郎拉姆. 三种内镜手术治疗结肠息肉的效果及安全性观察[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 78-81.
[4] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[5] 汤海琴, 郭秀枝, 朱晓素, 赵世娣. “隧道法”腹腔镜解剖性左半肝切除术的临床安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 674-677.
[6] 杨雪, 张伟, 尚培中, 宋创业, 尚丹丹, 张蔚. 胆囊十二指肠瘘结石经瘘口排出后自愈一例报道[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 707-708.
[7] 熊风, 林辉煌, 陈晓波. 铥激光在泌尿外科中的临床应用及研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 533-536.
[8] 彭永辉, 张文杰, 李炳根, 聂向阳, 吴凯, 杨六成. 单孔双针疝囊高位结扎术在儿童巨大腹股沟疝的临床应用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 566-569.
[9] 刘骏, 朱霁, 殷骏. 右美托咪定对腹股沟疝手术麻醉效果及安全性的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 570-573.
[10] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[11] 王峰杰, 王礼光, 廖珊, 刘颖, 符荣党, 陈焕伟. 腹腔镜右半肝切除术治疗肝癌的安全性与疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 517-522.
[12] 梁文龙, 曹杰, 黄庆, 林泳, 黄红丽, 杨平, 李冠炜, 胡鹤. 信迪利单抗联合瑞戈非尼治疗晚期结直肠癌的疗效与安全性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 409-413.
[13] 张政赢, 鞠阳, 刘晓宁. 二甲双胍对2型糖尿病患者大肠腺瘤术后复发的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 485-488.
[14] 魏红涛, 普布仓决, 格桑央宗, 黎燕, 益西旺扎, 李鹏. 拉萨地区上消化道溃疡患者幽门螺杆菌感染及治疗分析[J]. 中华临床医师杂志(电子版), 2023, 17(06): 662-665.
[15] 朴成林, 蓝炘, 司振铎, 冯健, 安峰铎, 李强, 谈明坤, 赵娜, 冷建军. 局部晚期右半结肠癌行结肠癌根治联合胰十二指肠切除术疗效分析:附5例报告[J]. 中华临床医师杂志(电子版), 2023, 17(06): 666-670.
阅读次数
全文


摘要